VentureBeat
RSS
Subscribe By Email
Main
DigitalMedia
LifeScience
CleanTech
Mobile/Comm
«
Amgen buys kidney-disease biotech ...
Main
Ultrasound clot-buster Ekos raises ...
»
Amgen buys kidney-disease treatment company, Ilypsa, for $420M
Matt Marshall
|
June 5th, 2007
See David Hamilton’s story at
VentureBeat Life Sciences
.
View the entire comment thread.
Trackback URL
VentureBeat Wire
Guest Columnists
Top Stories
Facebook hands classifieds service to Oodle
The Huffington Post confirms $25M third round
A new, elaborate $20 billion deal for ...
Mobile ad spending rises as iPhone effect ...
Joost is loosed on the iPhone. Looks ...
Recent Comments
Powered by Disqus
Recent Guest Columnists
Job Board
Regional Vice President of Sales
at
Marketing Technology Solutions
(Jersey City, NJ)
More Jobs »
|
Post a Job »
Links
About VentureBeat
Contact Matt Marshall (guarded by anti-spam solution)
Story Tips (anti-spam protection)
Advertise on VentureBeat (spam protection)
Contact VentureBeat Team (spam protection)
Freelance for VentureBeat (spam protection)
Blogroll
Twitter
VentureBeat Sponsors
Venturebeat Writers
Matt Marshall
, Editor-in-Chief
Dean Takahashi
, Lead Writer, DigitalMedia
Eric Eldon
, Editor, DigitalMedia
MG Siegler
, Writer, DigitalMedia
Anthony Ha
, Writer, VentureBeat
Chris Morrison
, Writer, CleanTech
For advertising, contact
Dan Kaplan (with anti-spam)
.
Log in
Forbes.com Technology Headlines
Sneakergate
Why Nokia Could Kill The Netbook
Videogame Misfires
Font Size
SMALL
|
MEDIUM
|
BIG